Biora Therapeutics(BIOR) - 2024 Q1 - Quarterly Report

Common Stock, par value $0.001 per share BIOR The Nasdaq Global Market ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 For the transition period from to Delaware 27-3950390 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Registrant's telephone number, including area code: (833) 727-2841 Indicate by check mark whether the registrant (1) has filed all reports required to ...